Literature DB >> 12638015

Mitochondrial cytopathies.

Janet Schmiedel1, Sandra Jackson, Jochen Schäfer, Heinz Reichmann.   

Abstract

Mitochondrial cytopathies represent a heterogeneous group of multisystem disorders which preferentially affect the muscle and nervous systems. They are caused either by mutations in the maternally inherited mitochondrial genome, or by nuclear DNA-mutations. Today, approximately 200 different disease causing mutations of mitochondrial DNA (mtDNA) are known, and due to the increased knowledge about nuclear genetics during the last few years, more and more nuclear mutations are being described. Owing to the non-uniform distribution of mitochondria in tissues and the co-existence of mutated and wildtype mtDNA (heteroplasmy) in these organelles, these disorders may present with a huge variety of symptoms, even if the same mutation is involved. Diagnostic investigations should include the measurement of serum and CSF lactate, neuroradiological tests and a muscle biopsy to show the characteristic ragged-red fibres and cytochrome c oxidase deficient cells and also to provide material for genetic analysis. To date, the treatment of these diseases remains supportive and should focus on typical complications such as cardiac dysrhythmia and endocrinopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638015     DOI: 10.1007/s00415-003-0978-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

Review 1.  Development of mitochondrial gene replacement therapy.

Authors:  Shaharyar M Khan; James P Bennett
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 2.  Cerebrospinal fluid and lumbar puncture: a practical review.

Authors:  Ben L C Wright; James T F Lai; Alexandra J Sinclair
Journal:  J Neurol       Date:  2012-01-26       Impact factor: 4.849

3.  Mitochondrial myopathy presenting with segmental corneal oedema and retrocorneal membrane.

Authors:  Marcus H Colyer; Kraig S Bower; Thomas P Ward; Ahmad A Hidayat; Prem S Subramanian
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

Review 4.  [Gene expression profiling of classic mitochondrial disorders. Its value in finding therapeutic strategies].

Authors:  S Mende; A Storch; H Reichmann
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

5.  Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy.

Authors:  G Pfeffer; H C F Côté; J S Montaner; C C Li; M Jitratkosol; M M Mezei
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

6.  Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice.

Authors:  Yae Sano; Akiko Furuta; Rieko Setsuie; Hisae Kikuchi; Yu-Lai Wang; Mikako Sakurai; Jungkee Kwon; Mami Noda; Keiji Wada
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

7.  Hemifacial presentation of mitochondrial myopathy.

Authors:  Nadeem Ali; James Acheson
Journal:  J Neurol       Date:  2011-01-26       Impact factor: 4.849

8.  Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes.

Authors:  Hoon-Chul Kang; Ji Won Kwon; Young Mock Lee; Heung Dong Kim; Hong Jin Lee; Si Houn Hahn
Journal:  Childs Nerv Syst       Date:  2007-06-19       Impact factor: 1.475

Review 9.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

10.  Adaptive optics scanning laser ophthalmoscopy images in a family with the mitochondrial DNA T8993C mutation.

Authors:  Michael K Yoon; Austin Roorda; Yuhua Zhang; Chiaki Nakanishi; Lee-Jun C Wong; Qing Zhang; Leslie Gillum; Ari Green; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.